– RECOVER-1 Phase 3 global trial successfully met all primary and secondary endpoints with statistically significant reductions across all major symptom domains in schizophrenia –
Reviva Reports Full Year 2023 Financial Results and Recent Business Highlights
Reviva Reports Full Year 2023 Financial Results and Recent Business Highlights
LabNews Media LLC
The Editors in Chief of labnews.ai are Marita Vollborn and Vlad Georgescu. They are bestselling authors, science writers and science journalists since 1994.More details about their writing on X-Press Journalistenbüro (https://xpress-journalisten.com).More Info on Wikipedia:About Marita: https://de.wikipedia.org/wiki/Marita_Vollborn About Vlad: https://de.wikipedia.org/wiki/Vlad_Georgescu
Ähnliche Beiträge
Trump Offloads Ebola-Infected American Citizen to Germany
Berlin/Washington (LabNews Media LLC) – A U.S. medical missionary infected with the Bundibugyo strain of Ebola virus disease (EVD) has been evacuated to Berlin’s Charité…
Kanada investiert 6,8 Millionen Dollar in KI-Projekte in Alberta
Edmonton (LabNews Media LLC) – Die kanadische Bundesregierung fördert fünf Projekte in Alberta mit insgesamt 6,8 Millionen Dollar über die Regional Artificial Intelligence Initiative (RAII).…
Ebola in Deutschland: Kaum Sonderisoliertstationen (SIS)
Berlin (LabNews Media LLC) – Die Weltgesundheitsorganisation (WHO) hat den Ebola-Ausbruch mit der Bundibugyo-Variante in der Demokratischen Republik Kongo und Uganda als internationale gesundheitliche Notlage…
